Sensidose is a pharmaceutical company. The company has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The company's product portfolio includes a number of brands and drugs intended for the treatment of, for example, Parkinson's. The main operations are in the Nordic region.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| BWG Invest Sàrl (William Gunnarsson) | 11,61 | 11,61 | 2022-05-12 |
| Christer Nyström | 10,26 | 10,26 | 2022-12-28 |
| Per Vasilis | 9,52 | 9,52 | 2022-12-28 |
| Lars-Åke Adolfsson | 7,88 | 7,88 | 2022-12-28 |
| Jungfrutomten Värdeinvest Aktiebolag | 6,82 | 6,82 | 2022-12-28 |
| Gerhard Dal | 4,60 | 4,60 | 2022-12-28 |
| Lars Tenerz | 4,35 | 4,35 | 2022-12-28 |
| Håkan Englund | 2,91 | 2,91 | 2022-12-28 |
| Anders Lundmark | 2,76 | 2,76 | 2022-12-28 |
| Per Nilsson | 2,46 | 2,46 | 2022-06-07 |
2023-02-16 Bokslutskommuniké 2022